VCAM-1

"CD106" redirects here. For the radio station formerly known as "CD106 the Wolf", see WNCD.
VCAM1
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
Aliases VCAM1, CD106, INCAM-100, vascular cell adhesion molecule 1
External IDs OMIM: 192225 MGI: 98926 HomoloGene: 838 GeneCards: VCAM1
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez

7412

22329

Ensembl

ENSG00000162692

ENSMUSG00000027962

UniProt

P19320

P29533

RefSeq (mRNA)

NM_080682
NM_001078
NM_001199834

NM_011693

RefSeq (protein)

NP_001069.1
NP_001186763.1
NP_542413.1

NP_035823.3

Location (UCSC) Chr 1: 100.72 – 100.74 Mb Chr 3: 116.11 – 116.13 Mb
PubMed search [1] [2]
Wikidata
View/Edit HumanView/Edit Mouse

Vascular cell adhesion protein 1 also known as vascular cell adhesion molecule 1 (VCAM-1) or cluster of differentiation 106 (CD106) is a protein that in humans is encoded by the VCAM1 gene.[3] VCAM-1 functions as a cell adhesion molecule.

Structure

The VCAM-1 gene contains six or seven immunoglobulin domains, and is expressed on both large and small blood vessels only after the endothelial cells are stimulated by cytokines. It is alternatively spliced into two known RNA transcripts that encode different isoforms in humans.[4] The gene product is a cell surface sialoglycoprotein, a type I membrane protein that is a member of the Ig superfamily.

Function

The VCAM-1 protein mediates the adhesion of lymphocytes, monocytes, eosinophils, and basophils to vascular endothelium. It also functions in leukocyte-endothelial cell signal transduction, and it may play a role in the development of atherosclerosis and rheumatoid arthritis.

Upregulation of VCAM-1 in endothelial cells by cytokines occurs as a result of increased gene transcription (e.g., in response to Tumor necrosis factor-alpha (TNF-α) and Interleukin-1 (IL-1)) and through stabilization of Messenger RNA (mRNA) (e.g., Interleukin-4 (IL-4)). The promoter region of the VCAM-1 gene contains functional tandem NF-κB (nuclear factor-kappa B) sites. The sustained expression of VCAM-1 lasts over 24 hours.

Primarily, the VCAM-1 protein is an endothelial ligand for VLA-4 (Very Late Antigen-4 or integrin α4β1) of the β1 subfamily of integrins. VCAM-1 expression has also been observed in other cell types (e.g., smooth muscle cells). It has also been shown to interact with EZR[5] and Moesin.[5]

Pharmacology

Certain melanoma cells can use VCAM-1 to adhere to the endothelium,[6] and VCAM-1 may participate in monocyte recruitment to atherosclerotic sites. As a result, VCAM-1 is a potential drug target.

References

  1. ↑ "Human PubMed Reference:".
  2. ↑ "Mouse PubMed Reference:".
  3. ↑ Cybulsky M, Fries JW, Williams AJ, Sultan P, Eddy RL, Byers MG, Shows TB, Gimbrone MA Jr, Collins T (1991). "The human VCAM1 gene is assigned to chromosome 1p31-p32". Cytogenet. Cell Genet. 58: 1852. doi:10.1159/000133735.
  4. ↑ "Entrez Gene: VCAM1 vascular cell adhesion molecule 1".
  5. 1 2 Barreiro O, Yanez-Mo M, Serrador JM, Montoya MC, Vicente-Manzanares M, Tejedor R, Furthmayr H, Sanchez-Madrid F (Jun 2002). "Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes". J. Cell Biol. 157 (7): 1233–45. doi:10.1083/jcb.200112126. PMC 2173557Freely accessible. PMID 12082081.
  6. ↑ Eibl RH, Benoit M (2004). "Molecular resolution of cell adhesion forces.". IEE Proc Nanobiotechnol. 151 (3): 128–32. doi:10.1049/ip-nbt:20040707. PMID 16475855.

Further reading

This article is issued from Wikipedia - version of the 5/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.